Human papillomavirus DNA in oral squamous cell carcinomas and normal oral mucosa

Acta Virologica

Volumn 47, Issue 1, 2003, Pages 11-16

  Kansky, A A ^a   Poljak, M ^b   Seme, K ^b   Kocjan, B J ^b   Gale, N ^b   Luzar, B ^b   Golouh, R ^c  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Human papillomaviruses; Normal mucosa; Oral carcinoma; Slovenia

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CARCINOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; MOUTH CARCINOMA; SMOKING; SQUAMOUS CELL CARCINOMA; WART VIRUS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; PAPOVAVIRIDAE;

EID: 0037571986     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Balaram P, Nalinakumari KR, Abraham E, Balan A, Hareendran NK, Bernard HU, Chan SY (1995): Human papillomaviruses in 91 oral cancers from Indian bete1 quid chewers-high prevalence and multiplicity of infections. Int. J. Cancer 61, 450-454.
2. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM (1994): Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J. Infect. Dis. 170, 1077-1085.
3. Bouda M, Gorgoulis VG, Kastrinakis NG, Giannoudis A, Tsoli E, Danassi-Afentaki D, Foukas P, Kyroudi A, Laskaris G, Herrington CS, Kittas C (2000): "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod. Pathol. 13, 644-653.
4. Eike A, Buchwald C, Rolighed J, Lindeberg H (1995): Human papillomavirus (HPV) is rarely present in normal oral and nasal mucosa. Clin. Otolaryngol. 20, 171-173.
5. Franceschi S, Bidoli E, Herrero R, Munoz N (2000): Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncology 36, 106-115.
6. Gale N, Poljak M, Kambič V, Ferluga D, Fischinger J (1994): Laryngeal papillomatosis: molecular, histopathologic, and clinical evaluation. Virchows Arch. 425, 291-295.
7. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ (2000): Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38, 357-361.
8. IARC (1995): Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 64, IARC Lyon, pp. 35-283.
9. Longo MC, Berninger MS, Hartley JL (1990): Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 93, 125-128.
10. Maden C, Beckmann AM, Thomas DB, McKnight B, Sherman KJ, Ashley RL, Corey L, Daling JR (1992): Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer in men. Am. J. Epidemiol. 135, 1093-1102.
11. Matzow T, Boysen M, Kalantari M, Johansson B, Hagmar B (1998): Low detection rate of HPV in oral and laryngeal carcinomas. Acta Oncol. 37, 73-76.
12. McKaig RG, Baric RS, Olshan AF (1998): Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 20, 250-265.
13. Miller CS, White DK (1996): Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma: a retrospective review of the literature. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 82, 57-68.
14. Miller CS, Johnstone BM (2001): Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 91, 622-635.
15. Parkin DM, Pisani P, Ferlay J (1999): Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int. J. Cancer 80, 827-841.
16. Poljak M, Cerar A (1993): Human papillomavirus type 16 DNA in oesophageal squamous cell carcinoma. Anticancer Res. 13, 2113-2116.
17. Poljak M, Orlowska J, Cerar A (1995): Human papillomavirus infection in esophageal squamous cell papillomas: a study of 29 lesions. Anticancer Res. 15, 965-970.
18. Poljak M, Gale N, Kambič V (1997): Human papilloma viruses: A study of their prevalence in the epithelial hyperplastic lesions of the larynx. Acta Otolaryngol. (Stockh) 527 (Suppl.), 66-69.
19. Poljak M, Cerar A, Seme K (1998a): Human papillomavirus infection in esophageal carcinomas: A study of 121 lesions using multiple broad spectrum polymerase chain reaction and literature review. Hum. Pathol. 29, 266-271.
20. Poljak M, Seme K, Gale N (1998b): Detection of human papillomaviruses in tissue specimens. Adv. Anat. Pathol. 5, 216-234.
21. Poljak M, Seme K, Gale N (2000): Rapid extraction of DNA from archival clinical specimens: our experiences. Pflug. Arch. Eur. J. Physiol. 439 (Suppl. 3), R42-R44.
22. Poljak M, Marin IJ, Seme K, Vince A (2002): Hybrid Capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high risk cocktail. J. Clin. Virol. 25 (Suppl. 3), S89-S97.
23. Rice PS, Mant C, Cason J, Bible JM, Muir P, Kell B, Best JM (2000): High prevalence of human papillomavirus type 16 infection among children. J. Med. Virol. 61, 70-75.
24. Sankaranarayanan R, Mohideen MN, Nair MK, Padmanabhan TK (1989): Aetiology of oral cancer in patients less than or equal to 30 years of age. Br. J. Cancer 59, 439-440.
25. Schwartz SM, Daling JR, Doody DR, Wipf GC, Carter JJ, Madeleine MM, Mao EJ, Fitzgibbons ED, Huang S, Beckmann AM, McDougall JK, Galloway DA (1998): Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J. Natl. Cancer Inst. 90, 1626-1636.
26. Scully C (2002): Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission. Oral Oncol. 38, 227-234.
27. Smith EM, Hoffman HT, Summersgill KS, Kirchner HL, Turek LP, Haugen TH (1998): Human papillomavirus and risk of oral cancer. Laryngoscope 108, 1098-1103.
28. Steinberg BM, DiLorenzo TP (1996): A possible role for human papillomaviruses in head and neck cancer. Cancer Metastasis Rev. 15, 91-112.
29. Sugerman PB, Shillitoe EJ (1997): The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship. Oral Dis. 3, 130-147.
30. Summersgill KF, Smith EM, Kirchner HL, Haugen TH, Turek LP (2000): p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 90, 334-339.
31. Syrjänen K, Syrjänen S (2000): Papillomavirus Infections in Human Pathology. Willey, Chichester, pp. 143-458.
32. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999): Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189, 12-19.
33. Watts SL, Brewer EE, Fry TL (1991): Human papillomavirus DNA types in squamous cell carcinomas of the head and neck. Oral Surg. Oral Med. Oral Pathol. 71, 701-707.
34. zur Hausen H (1996): Papillomavirus infection - a major cause of human cancers. Biochim. Biophys. Acta 1288, F55-F78.